Biotech Essentials

Companies & Industries

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 21.07.2021.

#cancerresearch
#biotech
#medicalnews
#biobanknews
#biorepository
#biobank
#stockexchange
#STATBreakthrough

Companies And Industries

@Biotechnology shared
On Jul 16, 2021
With $172 Million Raise, Wugen Brings Natural Killer Therapies to Solid Tumors Next https://t.co/3SMiTl012Y https://t.co/PlSsoKGzLV
Open
With $172 Million Raise, Wugen Brings Natural Killer Therapies to Solid Tumors Next

With $172 Million Raise, Wugen Brings Natural Killer Therapies to Solid Tumors Next

Its lead product, WU-NK-101, is already proving itself in an ongoing Phase I/II trial, demonstrating an "impressive complete response rate in relapsed/refractory AML."

@biospace shared
On Jul 19, 2021
@FrontierMeds raises $88.5 million to advance chemoproteomics program #cancerresearch #biotech https://t.co/dTGtYehS0d
Open
Frontier Medicines Raises $88.5 Million to Advance Chemoproteomics Program

Frontier Medicines Raises $88.5 Million to Advance Chemoproteomics Program

​Frontier Medicines will support the continued development of the company’s chemoproteomics drug discovery program, including lead asset, an inhibitor of KRASG12C.

@biobankingcom shared
On Jul 20, 2021
“The first step is to allow direct communication between the industry researcher and the source #biobank. Only then can the researcher begin to gain confidence in terms of the provenance information provided” - Dr @rhbio. #biorepository #biobanknews https://t.co/GxCKmyuChv
Open
Connecting Biobanks With Biotech and Pharma Successfully

Connecting Biobanks With Biotech and Pharma Successfully

Technology Networks recently had the pleasure of speaking with Robert Hewitt, founder and manager of Biosample Hub, a unique platform designed to connect biotech and pharmaceutical ...

@FiercePharma shared
On Jul 19, 2021
BioNTech makes a splash in cell therapy with purchase of factory, R&D platform from Gilead's Kite https://t.co/R6UQ1bCRWy
Open
BioNTech makes a splash in cell therapy with purchase of factory, R&D platform from Gilead's Kite

BioNTech makes a splash in cell therapy with purchase of factory, R&D platform from Gilead's Kite

Germany’s BioNTech has already risen to international prominence thanks to its Pfizer-partnered COVID-19 vaccine. Now, the mRNA specialist has lined up a deal for its first U.S. factory as ...

@BioWorld shared
On Jul 15, 2021
Cancer Research UK spin-offs bring in record investments in biotech bubble… https://t.co/H61vECdzQM
Open
Cancer Research UK spin-offs bring in record investments in biotech bubble

Cancer Research UK spin-offs bring in record investments in biotech bubble

Cancer Research UK took a significant hit when its U.K.-wide charity shop chain had to close last year because of the pandemic. But, according to latest figures, its commercial arm could ...

@biospace shared
On Jul 20, 2021
Weight loss-focused Gelesis heads to NYSE via SPAC deal, other IPOs filed #stockexchange #biotech https://t.co/jt0T7LmwvY
Open
Weight Loss-Focused Gelesis Heads to NYSE via SPAC Deal, Other IPOs Filed

Weight Loss-Focused Gelesis Heads to NYSE via SPAC Deal, Other IPOs Filed

The Boston-based company merged with Capstar Special Purpose Acquisition Corp. and will begin trading on the New York Stock Exchange under the ticker symbol “GLS.”

@FierceBiotech shared
On Jul 20, 2021
The transfer of Grossman comes around 14 months after Gilead entered into a 10-year agreement to co-develop cancer drugs with Arcus https://t.co/CMBZVZNxQ0
Open
In an unusual crossover, Gilead hires Arcus CMO Grossman, putting him in charge of cancer pact with his former biotech

In an unusual crossover, Gilead hires Arcus CMO Grossman, putting him in charge of cancer pact with his former biotech

Bill Grossman is leaving Arcus Biosciences to take up a position at Gilead, putting him in charge of the Big Pharma's collaboration with his former employers.

@matthewherper shared
On Jul 20, 2021
Messenger RNA vaccine pioneer Katalin Karikó shares her long journey to Covid-19 vaccines... a Q&A straight from last week's #STATBreakthrough Summit. https://t.co/VETFvfctDf v
Open
Messenger RNA vaccine pioneer Katalin Karikó shares her long journey to Covid-19 vaccines

Messenger RNA vaccine pioneer Katalin Karikó shares her long journey to Covid-19 vaccines

Speaking at the 2021 STAT Breakthrough Science Summit, Karikó shared her journey to developing the Pfizer/BioNTech Covid-19 vaccine.

Read more: Companies And Industries
weekly 21.07.2021
View archives
Back to home

Subscribe to Biotech Essentials - Companies & Industries.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Companies & Industries.
Privacy Policy

Sign up for the weekly Biotech Essentials - Companies & Industries newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Companies & Industries weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy